Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions

T Costa, J Lang, C Gless and A Herz

Department of Neuropharmacology, Max-Planck-Institut fuer Psychiatrie, Martinsried, Federal Republic of Germany.

High affinity GTPase in membranes from NG108-15 cells was differentially affected by opioid competitive antagonists; one type of antagonist [( N,N'-diallyl-Tyr1-Aib2,3]Leu-enkephalin) reduced the basal rate of GTP hydrolysis, whereas a second type (MR 2266) produced no changes. The inhibitory effect of the "active" antagonist was stereospecifically reversed by the "inactive" antagonist, indicating that it was receptor mediated. This suggests that part of basal GTPase activity in this system results from a spontaneous interaction between opioid receptors and GTP-binding proteins (G proteins) and that some antagonists exhibit negative intrinsic activity by hindering such an interaction. The inhibitory effect of the antagonist was minimal in the presence of Na+ and maximal when Na+ was replaced by K+ in the reaction. When the ratio [Na+]/[K+] was progressively increased at constant [Cl-], total GTPase activity (i.e., net difference between activity stimulated by agonist and that inhibited by antagonist) did not change, but the activity measured in the absence of ligand was selectively decreased. Thus, Na+ does not alter the total proportion of G proteins that can be activated by ligand-occupied receptors and instead regulates the interaction between receptor and G protein in the absence of ligand. Upon examination of several opioid agonist and antagonists, we found an inverse relation between the intrinsic activity (either negative or positive) of each ligand and the sensitivity to Na+ of the GTPase elicited upon occupation of the receptor by that ligand. Sodium-mediated and ligand-mediated regulations of GTPase had identical requirements for Mg2+ [( Mg2+]free greater than 10 microM), and were both abolished with a similar potency by pertussis toxin. There was no effect of Na+ on the basal rate of GTP hydrolysis of Gi/Go purified from bovine brain. However, addition of these proteins to membranes prepared from cells that had been previously exposed to pertussis toxin partially restored both receptor- and sodium-mediated regulations of GTPase in parallel and in a concentration-dependent fashion. We conclude that sodium ions play a key role in the mechanism underlying the spontaneous interaction between "empty" receptors and G proteins in intact membranes.

Volume 37, Issue 3, pp. 383-394, 03/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. Bongers, K. M. Krueger, T. R. Miller, J. L. Baranowski, B. R. Estvander, D. G. Witte, M. I. Strakhova, P. van Meer, R. A. Bakker, M. D. Cowart, et al. An 80-Amino Acid Deletion in the Third Intracellular Loop of a Naturally Occurring Human Histamine H3 Isoform Confers Pharmacological Differences and Constitutive Activity J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 888 - 898. [Abstract] [Full Text] [PDF]

				A. Makino, E. R. Prossnitz, M. Bunemann, J. M. Wang, W. Yao, and G. W. Schmid-Schonbein G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1633 - C1639. [Abstract] [Full Text] [PDF]

				M. Engstrom, J.-M. Savola, and S. Wurster Differential Efficacies of Somatostatin Receptor Agonists for G-Protein Activation and Desensitization of Somatostatin Receptor Subtype 4-Mediated Responses J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1262 - 1268. [Abstract] [Full Text] [PDF]

				P. A. Zaki, D. E. Keith Jr., J. B. Thomas, F. I. Carroll, and C. J. Evans Agonist-, Antagonist-, and Inverse Agonist-Regulated Trafficking of the delta -Opioid Receptor Correlates with, but Does Not Require, G Protein Activation J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1015 - 1020. [Abstract] [Full Text]

				R. Seifert Monovalent Anions Differentially Modulate Coupling of the beta 2-Adrenoceptor to Gsalpha Splice Variants J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 840 - 847. [Abstract] [Full Text] [PDF]

				S. M. Wade, K.-L. Lan, D. J. Moore, and R. R. Neubig Inverse Agonist Activity at the {alpha}2A-Adrenergic Receptor Mol. Pharmacol., March 1, 2001; 59(3): 532 - 542. [Abstract] [Full Text]

				S. Sagan, P. Karoyan, G. Chassaing, and S. Lavielle Further Delineation of the Two Binding Sites (R*n) Associated with Tachykinin Neurokinin-1 Receptors Using [3-Prolinomethionine11]SP Analogues J. Biol. Chem., August 20, 1999; 274(34): 23770 - 23776. [Abstract] [Full Text] [PDF]

				C. E. Tedford, J. G. Phillips, R. Gregory, G. P. Pawlowski, L. Fadnis, M. A. Khan, S. M. Ali, M. K. Handley, and S. L. Yates Development of trans-2-[1H-Imidazol-4-yl] Cyclopropane Derivatives as New High-Affinity Histamine H3 Receptor Ligands J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1160 - 1168. [Abstract] [Full Text]

				K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]

				D. E. Selley, Q. Liu, and S. R. Childers Signal Transduction Correlates of Mu Opioid Agonist Intrinsic Efficacy: Receptor-Stimulated [35S]GTPgamma S Binding in mMOR-CHO Cells and Rat Thalamus J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 496 - 505. [Abstract] [Full Text]

				Q. Tao and M. E. Abood Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 651 - 658. [Abstract] [Full Text]

				C. M. Colantonio, W.-K. Kwan, W. Czerwinski, J. Mitchell, and B. P. Schimmer Altered G Protein Activity in a Desensitization-Resistant Mutant of the Y1 Adrenocortical Tumor Cell Line Endocrinology, February 1, 1998; 139(2): 626 - 633. [Abstract] [Full Text] [PDF]

				P. G. Szekeres and J. R. Traynor Delta Opioid Modulation of the Binding of Guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 Cell Membranes: Characterization of Agonist and Inverse Agonist Effects J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1276 - 1284. [Abstract] [Full Text]

				M. J. Clark, P. J. Emmerson, A. Mansour, H. Akil, J. H. Woods, P. S. Portoghese, A. E. Remmers, and F. Medzihradsky Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 501 - 510. [Abstract] [Full Text]

				A. J. Williams, A. D. Michel, W. Feniuk, and P. P. A. Humphrey Somatostatin5 Receptor-Mediated [35S]Guanosine-5'-O-(3-thio)triphosphate Binding: Agonist Potencies and the Influence of Sodium Chloride on Intrinsic Activity Mol. Pharmacol., June 1, 1997; 51(6): 1060 - 1069. [Abstract] [Full Text]